Cancer News: Breast
Breast cancer patients who achieved ovarian suppression with the hormonal drug triptorelin had more chances to recover ovarian function, a new study shows.
Counting the symptoms of breast cancer-related lymphedema appeared to be diagnostically relevant and a cost-effective initial screening tool for lymphedema.
Delaying treatment and chemotherapy influences the survival rates of breast cancer patients, two large U.S. studies suggest.
Postmenopausal women with ductal carcinoma in-situ treated with anastrozole saw no difference in outcome compared to treatment with tamoxifen.
Early-stage breast cancer patients who received breast-conserving surgery plus radiation therapy instead of mastectomy lived longer, scientists report.
Patients with triple-negative breast cancer who had no residual invasive cancer detected after pre-surgery chemotherapy lived longer, scientists discovered.
Premenopausal women whose invasive breast cancers were of the luminal A subtype did not benefit from a treatment with adjuvant chemotherapy.
Breast cancer patients with residual disease after pre-surgery chemotherapy lived longer after being treated with the chemotherapy agent capecitabine.
The combination of the palbociclib with paclitaxel (Taxol) induced positive patient outcomes when administered to estrogen-receptor positive breast cancer patients.
The monoclonal antibody (denosumab) given as adjuvant therapy with aromatase inhibitors reduced disease relapse rate in breast cancer patients.
Counseling before and after a genetic cancer screening helped BRCA 1/2-negative patients make informed decisions and deal with anxiety, a new research reveals.
Breast cancer survivors at risk of developing leukemia due to chemotherapy and/or radiation share certain characteristics, a new analysis shows.
No link was identified between risk of recurrence and antidepressant use in breast cancer patients taking an anti-cancer drug and an antidepressant.
Initial breast surgery was linked to increased and durable survival rates in women with stage IV breast cancer, a new study points out.
Learning how to manage stress early in their breast cancer treatment helped patients live longer without the disease, a randomized trial shows.
Women at high-risk of breast cancer could benefit from regular physical activity, according to a new research.
Breast conservation therapy should be suggested as a treatment option to breast cancer patients with larger tumors, researchers reported.
The analysis of a trial revealed that HER2-positive breast cancer patients benefited more from receiving chemotherapy alone than chemotherapy plus trastuzumab.
Breast cancer survivors improved their physical functionality lost due to chemotherapy when participated at a six-month weight training program, a new study shows.
A retrospective analysis revealed that elderly women with early stage triple negative breast cancer benefited from adjuvant radiation therapy after lumpectomy.
The emotional state of a breast cancer patient who undergoes surgical intervention is found to be a risk factor for acute postoperative pain, a new study reveals.
Acupuncture may offer relief for breast cancer patients against hot flashes, particular common when taking estrogen-taking therapies, according to a new study.
Breast cancer patients often face difficulties in losing weight after treatment. Researchers now report that these women can lose weight with a personalized intervention.
Young women with breast cancer may refuse to be treated with the effective treatment, tamoxifen, due to the drug’s side effects on fertility.
The side effects of hormone therapy as well as a poor doctor-patient communication may make breast cancer patients to intentionally or unintentionally miss a dose.
Chemotherapy proved to be inefficient for breast cancer patients over the age of 70, a new study reveals.
Two currently available treatments, aromatase inhibitors and bisphosphonates benefited substantially breast cancer patients.
A 14-year study reports that additional radiation, although it did not increase overall survival, benefited breast cancer patients as it reduced cancer recurrence.
Combining lapatinib and trastuzumab led to positive outcomes in metastatic breast cancer patients as it proved to be active and well-tolerated.
Chemotherapy may lead to weight gain in breast cancer survivors with a family history of the disease, a new prospective study suggests.